Oculus Innovative Sciences Announces Preliminary Results From 40-Patient Feasibility Study for Treatment of Acne With Enhanced Microcyn Hydrogel…

Company to Explore Partnerships for Newly Enhanced Microcyn Hydrogel, Targeting $3.3 Billion Over-the-Counter Medicated Skin Care Market

Related posts:

1. Oculus Innovative Sciences Announces Preliminary Results From 40-Patient Feasibility Study For Treatment Of Acne With The Microcyn(R) Technology Oculus Innovative Sciences, Inc. (Nasdaq: OCLS), a healthcare company that...
2. AmDerma Pharmaceuticals Exercises Option to License Rights to Oculus Innovative Sciences Microcyn(R)-Based Acne Drug Candidate PETALUMA, Calif. ...
3. Onset Therapeutics Announces Results Of BenzEFoam™ Skin Hydration Study Onset Therapeutics, a specialty pharmaceutical company focused in dermatology, today...
4. Severe cutaneous reaction to cetuximab with possible association with the use of over-the-counter skin care products in a patient with oropharyngeal… DISCUSSION: Our report describes a sudden flare-up of a skin...
5. Elorac, Inc. Announces Clinical Results Of Carbamide Peroxide Studies For The Treatment Of Acne Elorac, Inc., a rapidly growing specialty pharmaceutical company focused on...

Leave a comment

Name (required)

E-mail (required)

URI

Your Message